MASLD affects more than 1 in 4 individuals with IBD and is most prevalent among adults, men, and individuals living in certain geographic regions.

The iSNP systems genomics pipeline models how non-coding SNPs cumulatively impact cellular signalling and gene regulatory networks, revealing patient-specific mechanisms linking disease-associated ...

Nerandomilast, a PDE4B inhibitor, is a new treatment option for IPF, showing better tolerability than nintedanib and ...

Inflammatory bowel disease (IBD) in children and adolescents represents a rapidly growing field of research within pediatric gastroenterology. Over the past ...

Infliximab biosimilar CT-P13 is noninferior to originator infliximab across long-term clinical outcomes, including treatment failure and steroid dependence.

Researchers found a bidirectional link between type 2 diabetes and IBD, with each condition increasing the risk for incident onset of the other.